Gene Expression Kit Designed for High-throughput Automated Usage
By LabMedica International staff writers Posted on 04 Oct 2015 |
A newly released kit for gene expression measurement was designed for high-throughput use with 384-well microplates.
The Affymetrix (Santa Clara, CA, USA) QuantiGene Singleplex Assay does not require nucleic acid purification, reverse transcription, or PCR amplification. Packaged for use on 384-well microplates, the assay is readily adaptable for automated high-throughput screening.
The manufacturer recommends using the QuantiGene assay for screening of compounds in drug discovery, for biomarker validation, and in siRNA (small, inhibiting RNA) knockdown studies. The assay works with a wide range of sample types, including heavily degraded and cross-linked RNA in FFPE (formalin fixed paraffin embedded) samples and RNA circulating in blood.
“This new, automation-friendly 384-well assay format fits with current workflows because cells are most commonly cultured in 384-well plates for high-throughput screening,” said Brian McLucas, product manager at Affymetrix. “Furthermore, the limiting step with qPCR is RNA purification, which is completely avoided with QuantiGene assays. Gene expression-based high-throughput screening of hundreds of thousands of compounds can be carried out in just weeks.”
Related Links:
Affymetrix
The Affymetrix (Santa Clara, CA, USA) QuantiGene Singleplex Assay does not require nucleic acid purification, reverse transcription, or PCR amplification. Packaged for use on 384-well microplates, the assay is readily adaptable for automated high-throughput screening.
The manufacturer recommends using the QuantiGene assay for screening of compounds in drug discovery, for biomarker validation, and in siRNA (small, inhibiting RNA) knockdown studies. The assay works with a wide range of sample types, including heavily degraded and cross-linked RNA in FFPE (formalin fixed paraffin embedded) samples and RNA circulating in blood.
“This new, automation-friendly 384-well assay format fits with current workflows because cells are most commonly cultured in 384-well plates for high-throughput screening,” said Brian McLucas, product manager at Affymetrix. “Furthermore, the limiting step with qPCR is RNA purification, which is completely avoided with QuantiGene assays. Gene expression-based high-throughput screening of hundreds of thousands of compounds can be carried out in just weeks.”
Related Links:
Affymetrix
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples